Patient Safety meetings & conferences

Society for Acupuncture Research 2013 Conference

Impact of Acupuncture Research on 21st Century Health Care

April 19-21, 2013 University of Michigan Ann Arbor, Michigan, USA

Co-sponsored by: University of Michigan Department of Anesthesiology and Program in Integrative Medicine

The rising incidence of chronic disease and stress-related illness in the West has led to an increased utilization of acupuncture
as a contemporary health care option. A major reason for this increase in usage is that acupuncture has heeded the call for evidence-based medicine, with a broad range of clinical trials, surveys of safety, and basic science studies of physiological action all contributing to its growing acceptance. The 2013 SAR conference will explore diverse areas of acupuncture research, emphasizing their potential to affect health policy decisions and enhance clinical practice.

-- Leading researchers from the U.S. and abroad will present keynote addresses, participate in symposia and panels, and lead workshops assessing recent progress, challenges and opportunities for the field.

-- Representative speakers from the national and international acupuncture research communities will present original data in three major areas: clinical research, basic science and research methodology.

-- A pre-conference workshop will focus on “Current status and issues in acupuncture research for practitioners, students, and educators new to this field.”

See www.acupunctureresearch.org for more details about the conference program as available.

Society for Clinical Data Management 2012 Annual Conference

The SCDM Annual Conference is the world's largest education event for clinical data managers and related professionals, attracting over 600 attendees from across North America and around the world.

The 2012 Annual Conference runs September 22-25 in Los Angeles, California.

Topics

Adaptive Trials: What are they, and how are they different for Data Managers?

What does it mean to be an adaptive trial? What exactly gets adapted? How does that happen?
What does the FDA think about this? The industry?
How does an Adaptive Trial differ for Data Management?

Working Together for Success – CDMs and CRAs in the 21st Century

Partnership lessons from the perspective of the CRA
Analytical tools for the DM and the CRA
Areas of synergy – where the CRA and CDM should work more closely
How can we, collectively, affect overall study quality?
Understanding each other's perspectives, while still achieving clinical study success
Who's on First, What's on Second – Who's Going to Resolve that Query!!

Enhancing Research Through Metadata-driven Processes

Case Studies from implementers who have implemented metadata-driven processes
Metrics on how implementing standards ""up front"" has improved timelines and reduced costs
Case studies on how having your clinical data repository in a standard format enhanced your research
Case studies from implementers of eSource or EHR for clinical research
Case studies of collaborating with partners (CROs, vendors,other research partners) in a metadata driven process

Data Management: Core Functions Under the Spotlight

Efficacy in Serious Adverse Event (SAE) Reconciliation
The Role of the CRF Designer – Present and Future
Dictionary Coding – Is Certification Necessary?
Other important Data Management specialty roles/functions

Medical Devices Session

Are a Data Manager's skills transferable between the drug and device industries?
What are the main challenges for a data manager in the device industry?
How is the changing regulatory landscape affecting our deliverables?
Review and discussion of the newly released CDISC SDTM Device domains

The Benefits of Informatics to Data Managers

Infrastructure changes needed to accommodate the new technology which will impact and facilitate data collection, management and electronic exchange… Electronic Health Records, Data Standards, Health Information Exchange (HIE)
Skills required in the future environment of data collection, data sharing and electronic data exchange between organizations.
Opportunities for gaining knowledge and experience that will facilitate new skills and advance career goals in the new technology age
The look at data management in the future what does it look like and who are catalyst (CDISC, HL7, EHR vendors, HIEs, Pharma, Regulatory Agencies…)

Managing Data (and more) at the Program Level

Ensuring application and usage of standards across the program
Planning, resourcing and timeline management
Challenges/Benefits of working from the first Phase 1 to the first Phase IV

eSource: It's more than Data

Clarify differences between Source and CRF (Regulatory, Data Standards, Site Impact)
eSource impact on data management expectations, infrastructure, and workflow
Define operational and financial benefits of eSource relative to EDC

Clinical Endpoint Adjudication: A clinical trial within a clinical trial?

What is Endpoint Adjudication and when is it necessary
What Regulators want to know about Endpoint Adjudication
Issues and Opportunities for efficiencies

How to be a Leader in Data Management

Project Management Techniques for the Data Manager
How to Successfully Collaborate with Cross Functional Team members for optimal results

Finding or Becoming a Mentor in Data Management

An outline of the most effective ways of mentoring and training CDMs for leadership roles
How to take control of your own development and find a mentor to help you grow in your career
Not everyone is a natural born mentor, what are important qualities to look for when choosing a mentor?
Experience is the best teacher, whether positive or negative - what personal experience can you share in assisting a CDM in finding a mentor? Or what tips do you have for mentoring someone?

Outsourcing DM: How to Get the Most Value out of a Partnership

CRO oversight by sponsor - balance between control and micro-managing
Sharing tools: Vendor Oversight Plan, Transition Plan, QC Plan
If only one service is outsourced (e.g. coding), how to work with DM team?

Risk-based Approach to Monitoring: The Way of the Future

Variety of alternative approaches to assess data quality and patient safety
Centralized monitoring of data quality, site characteristics and performance metrics that can trigger on-site monitoring
Guidelines for risk based monitoring plans.
Key challenges of integrating this approach into your trials.

CDM role in the FDA guidance of Risk-Based Approach to Monitoring

Will this approach compromise data quality and integrity?
What kind of challenges will pose to data managers?
What new role, responsibilities and skill sets will be needed for data managers to provide value in this approach?

Technology Drivers as Motivators for Change

A perspective on how Electronic Health Records, the push for Centralized Monitoring, analytical tools, Mobility and Portals drive toward a change in roles and activities to be performed by CDM now and in the future.
What might the landscape look like in technology and how this will result in a shift in priority for CDM in alignment with shifting roles in monitoring and the needs of statistics.

Rock, Paper, Scissors, Technology: The Impact of Technological Advances on the DM Landscape

The risk of layers of more complex process instead of overall improvement in process when introducing new technology. Are we as bogged down as when we used paper data collection.
Ways in which advances in technology have increased productivity, provided greater or more varied access to data, and improved the efficiency with which Clinical Data Managers are able to perform their jobs.
The many pitfalls associated with adopting new technology and methods that we can use to address these issues.

6th Forum on Respiratory Tract Infections

November 28-30 2012 Barcelona, Spain

The 6th RTI Forum in the series is now proposed in response to important advances and novel issues in the matters of epidemiological, diagnostic and therapeutic events, including significant new agents, both anti-microbial and adjunctive, early recognition of bacterial disease (and rapid pathogen identification) and preventative vaccines. Most of these will be approaching the clinical interface within the next 2-3 years. They urgently merit both objective interdisciplinary evaluation and wider dissemination to leaders in their clinical application. The 6th RTI Forum offers a unique opportunity to discuss these issue with experts in respiratory Infection in an intimate and informal atmosphere and we hope to welcome you in Barcelona!

Topics for RTI 2012 Forum include:

The continued role of Ps aeruginosa in broncho-pulmonary disease.
The “Last” antibiotic decade (the possible future without antibiotics)
The re-emergence of preventable respiratory disease: pertussis, measles, varicella, mumps
Unanswered questions in AECB – what data must new trials provide
Inhaled therapy – an expanding future?
Nosocomial MRSA pneumonia
CA-MRSA
Ventilator-associated-pneumonia (or VA tracheitis)
Tuberculosis / MDR-TB: non-MTB mycobacteria in RTI
Current role of pneumococcal vaccines: efficacies and deficiencies?
Community acquired pneumonia
Healthcare Associated pneumonia
Development of the vancomycins
Aspergillosis
Influenza then and now
Influenza vaccines (after Bird flu where next)
Faculty Advisory Board: Any Questions?

Secretariat - Publicreations
74, Bd d’Italie, Monte Carlo - MC98000 (Monaco)
Ph.: +377 9797 3555 - Fax: +377 9797 3550
Email: rti@publicreations.com

4th Annual Personalized Medicine Conference

September 12-13, 2012 Boston, Massachusetts

Personalized medicine has the potential to revolutionize medical care by utilizing an improved understanding of genetics and molecular biology to allow for better diagnostic tests, more precise diagnoses, greater predictability of disease course, and improved patient safety by selecting not only the right drug for a patient but also the proper dosage to reduce adverse effects. Speakers and panelists will answer the following key questions:

What types of challenges need to be met in order to realize the true commercial potential of personalized medicine?
Will insurers fund the genomic revolution?
What types of validation requirements are they looking for?
What will be their criteria for reimbursement?
What are the real-world challenges to successful adoption of molecular/companion diagnostics?
Who needs to partner in order to advance the field of personalized medicine?
What are the goals, utility and challenges associated with Rx-Dx partnerships?
How and when are relationships being initiated today?
How are companies navigating their way through the world's regulatory bodies?
What kind of impact are Pharmacy Benefit Managers (PBMs) and for that matter new genetic testing benefit managers going to have on the future of personalized medicine?
What types of efforts are being made to influence adoption via physician education?

Arrowhead Publishers and Conferences
5412 Irving Avenue South
Minneapolis
MN
55419
USA

E-mail: enquiries@personalizedmedicinepartnerships.com
Telephone: 312-244-3703
Fax: 312-244-3703
http://www.arrowheadpublishers.com

Third Annual International Pediatric Antimicrobial Stewardship Conference

Sponsored by Children’s Mercy Hospitals and Clinics and the Pediatric Infectious Diseases Society

May 31 - June 1, 2012 Kansas City, Missouri

Meeting Topics

May 31st

Nuts and bolts: Initiation and implementation of an Antimicrobial Stewardship Program (ASP)

June 1st

Stewardship strategies in the outpatient setting
Empiric disease specific antimicrobial utilization
Utilization of microbiology laboratory data to guide ASP decisions
International efforts involving ASPs
Useful Strategies for inpatient antimicrobial stewardship
ASP evaluation and outcome metrics

Learning Objectives

At the completion of the course, healthcare professionals will be able to:

Implement and evaluate a pediatric ASP
Understand the importance of Pediatric ASPs on a global scale
Identify strategies to improve outpatient antibiotic use
Design evaluation strategies for your ASP
Identify barriers to and potential stategies to optimize ASP outcomes

Meeting Location

The meeting will occur at Children's Mercy Hospitals and Clinics in Kansas City, MO.

Interested in Meeting

Please contact Jason Newland at jnewland1@cmh.edu or Christy Phillips at cphillips@idsociety.org if you are interested in attending the meeting

Forces of Change: New Strategies for the Evolving Health Care Marketplace

September 10–14, 2012  Boston, Massachusetts

2012 Program Theme: Driving successful implementation in a time of disruption, innovation, and change

Forces of Change:

Addresses health care organizational strategy:

Harvard’s Forces of Change program offers health care executives and emerging leaders direction on strategic issues at their organization. In an economic landscape which is demanding improved efficiency, reduced costs, and enhanced quality, Forces addresses critical success factors at the intersection of health care and business with a focus on how to effect change.

Explores leadership issues specific to health care:

Beginning with a discussion of current market dynamics Forces identifies opportunities for greater alignment between nine key stakeholders, analyzes the factors that exacerbate existing stakeholder misalignments, and outlines the steps necessary for achieving positive change. The second part of Forces defines the dominant market responses to the current health care landscape, and examines the potential and limitations of these predictable attempts to improve efficiency and effectiveness. Finally, Forces details activation mechanisms health care leaders can use to fulfill the promise of new initiatives and create a sustainable competitive advantage.

Informs health care leaders of best practices:

Supplementing the last day of Forces, experts in the field of quality and process improvement will provide immediately applicable strategies and tactics on process improvement in health care on Friday, September 14, 2012. The program will focus on how to reduce waste in processes, improve productivity, and foster innovation in health care to promote patient safety and quality care.

The September 14th sessions of Forces of Change are open only to participants of Attaining Process Improvement Excellence in Health Care.

Who should participate in Forces of Change:

Forces of Change is ideal for those seeking to improve the quality of patient care, reduce the cost of providing that care, enhance stakeholder satisfaction, address critical workforce challenges, and in the process, create a unique and sustainable competitive advantage. Forces is also recommended for corporate executives responsible for the strategy, design, and delivery of health care programs. Most importantly, the program is designed for the leader who is driven to transform ideas into action.

Past Forces participants include:

C-Suite executives, presidents, and vice presidents from hospitals, health systems, and health plans
Chiefs and chairs of academic teaching hospitals
Patient safety officers
Foreign and domestic governmental agency representatives
Physicians, managers, and directors with increasing strategic responsibilities
Purchaser and supplier representatives
Other diverse stakeholders in the health and business sectors

Forces of Change Participants Will:

Initiate change and advance projects from idea to implementation with actionable strategies

Implement best practices for health information technology (HIT)

Discuss innovation in patient-centered medical homes and ACOs with clinical leaders

Explore options for process improvement in clinical settings

Overcome the limitations of current approaches to improving patient safety and developing systemic changes to health care services

Gain insight on reform implementation from Massachusetts health care leaders

Improve relationships among health care stakeholders

Build trust for your department or organization, and discuss the critical role of trust in health care

Learn key steps for successful clinical change from hospital leaders

To contact us: 617.384.8692 • contedu@hsph.harvard.edu

9th International Conference on Wearable Micro and Nano Technologies for Personalized Health (pHealth)

June 26-28, 2012 Porto, Portugal

The pHealth conference has emerged as the leading international meeting on wearable micro and nano technologies for personalized medicine. Starting in 2004, pHealth has attracted scientists for various technologies, medical doctors, policy makers from the healthcare industry, hospital administration and allied professionals.

Collecting a dynamic professional community from Europe and all over the world pHealth has given visibility to the tremendous potential of micro and nano technologies not only for the future of medicine, but also for the improvement of healthcare processes today.

Microsystems, smart textiles, telemedicine, smart implants and sensor-controlled medical devices have become important enablers for monitoring and treatment in both inpatient and outpatient care. This is, however, just the beginning of revolutionary changes and significant opportunities are given for patients, companies and the healthcare industry.

The multilateral benefits of pHealth technologies for all three stake-holders lead to a triple win situation with enormous potential, not only for medical quality improvement and industrial competitiveness, but also for managing healthcare cost.

29th International Conference of the International Society for Quality in Health Care

October 21-24, 2012 Geneva, Switzerland

The International Society for Quality in Health Care is a non profit, independent organisation with members in over 70 countries, ISQua's conference offers a unique opportunity for delegates to share expertise and knowledge via a multidisciplinary forum including;

6 Plenary Presentations
Over 1,000 delegates
Representatives from 70 countries
In excess of 250 presentations
500 posters
Over 100 expert speakers
25 hours of networking
Major social events

The Geneva 2012 Conference Programme will be structured around the following sub-themes:

Patient Centered Care
Education in Safety and Quality

Governance, Leadership and Health Policy

Patient Safety Systems
Measuring Service Performance and Outcome

Integrated Care and Interface with Primary and Social Care
Innovative Technologies using e-health and Health Technology Assessment

Quality and Safety in Transitional and Developing Countries
Accreditation and Regulation of Systems and Professionals

Third International Conference on Violence in the Health Sector--Linking Local Initiatives With Global Learning

October 24-26 2012 Vancouver, Canada

Work related aggression and violence within the health and social services sector is a major problem which diminishes the quality of working life for staff, compromises organizational effectiveness and ultimately impacts negatively on the provision and quality of care. These problems pervade both service settings and occupational groups.

Considerable attention and advancements in addressing this problem have been achieved from service and organizational perspectives nationally and internationally. Following two successful conferences in 2008 and 2010 in Amsterdam, the 3rd International Conference on Violence in the Health Sector, will take place in Vancouver, Canada, from October 24-26 2012. In addition to raising awareness the 2012 conference will provide a platform to share international developments, with a particular emphasis on best practice research and initiatives to effectively respond to the problem.

The specific aims of the conference are:

To sensitize stakeholders to the issue of violence in the health care sector,
To understand the manifestations and the human, professional and economic implications of violence in the health care sector,
To promote effective sustainable initiatives and strategies to create safe environments for workers and clients in the health care sector,
To present initiatives which respond to the problem, and have transferable learning for efforts in broader service and geographical contexts.

Conference sub-themes:

Patterns of aggression and/or violence within healthcare:
All manifestations of aggression and/or violence irrespective of who the perpetrator or victim is (staff, service user, co-worker, others) including:

1. Verbal aggression/violence

2. Physical aggression/violence

3. Sexual intimidation/harassment

4. Psychological aggression/violence

5. Horizontal/lateral aggression/violence, like bullying, mobbing and intimidation

6. Financial abuse

7. Organizational/hierarchical aggression/violence

Impact of aggression and/or violence within healthcare:

8. Physical/Injury impacts of aggression/violence

9. Emotional/Psychological impacts of aggression/violence

10. Financial impacts of aggression/violence

11. Service related impacts of aggression/violence

12. Professional, legal and ethical impacts of aggression/violence

Initiatives and solutions to aggression and/or violence within healthcare:

13. Creating aggression and violence minimizing cultures

14. The minimisation/reduction of seclusion, restraint and coercive measures

15. Engaging with service user in seeking solutions

16. Education and training

17. Quality safety and risk reduction initiatives

18. Policy/guidance on best practice initiatives

The key theme of the conference on this occasion is on initiatives which inform responses to the problem of aggression and/or violence within the health sector.

5th Nursing Economic$ Summit

June 6-8, 2012 Washington, DC

The focus of the Summit is leadership and practice.

.